US reform may boost drug sales by $35 bn
Extending the US federal health scheme for the elderly to cover prescription drugs could boost pharmaceutical industry sales by up to $35 bn a year, according to analysis of official data. The long
Extending the US federal health scheme for the elderly to cover prescription drugs could boost pharmaceutical industry sales by up to $35 bn a year, according to analysis of official data. The long